Home

Swenoteca abc

The ABC-study. The MIR-study. Other studies. Meetings. Publications. Working group. About. More. Annal Meeting November 12th. Dear SWENOTECA friends. Dear SWENOTECA friends. This years Annual Meeting will take place at Gardermoen Radisson Blu March 16, from 1000-1600. Here you can find. The ABC-study. The MIR-study. Other studies. Meetings. Publications. Working group. About. More. Management programs. The management programs are the fundation of the SWENOTECA collaboration. They provide clinician with guidelines for treating all patients with testicular cancer

The Swedish and Norwegian Testicular Cancer Group (SWENOTECA) is a binational group of phycisians focused on ensuring patients with testicular cancer optimal diagnosis, treatment and survivorship.. SWENOTECA was initiated in 1981 and provides multidisciplinary, comprehensive management programs for staging, treatment and follow-up of testicular germ-cell cancer -SWENOTECA VII, 2007 Seminomatous Germ Cell Testicular Cancer. A revised continuation of SWENOTECA V : Uppföljningsschema-Alla seminom Gäller fr o m 2012 04 04 : Patientinformation: Seminom utan tecken till spridning, stadium I. -Svensk information Gäller fr o m 2007 01 -Norsk information Gäller fr o m 2007 01 : Blanketter för inrapporterin Dear SWENOTECA friends. The new protocol for seminoma and nonsemima germ cell cancers have just been published, and can be found under management programs. Featured Posts. Annual meeting 2019. Annual Meeting Arlanda Mar 15, 2018. The SWENOTECA ABC-study. Annual meeting in Trondheim 11.-12 Join the SWENOTECA mailing list.  Contact Us. SWENOTECA. Kreftklinikken, St. Olavs Hospital, Postboks 3250 Sluppe Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer (SWENOTECA-ABC) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators

The follow-up after diagnosis and treatment should be aimed to detect possible relapses as early as possible. The current follow-up schedules have been developed based on SWENOTECAs own experiences from treating many thousands patients with testicular cancer 40-45 % of patients with testicular cancer are diagnosed with nonseminoma, of these 55-60 % will only have disease in the testicle while 40-45 % will have metastatic disease to lymphnodes, the lungs or other organs 2012-02-27 /MRD Registreringsblankett SWENOTECA Seminom 1. Definition av testikulär primärtumör (ICD C 62): A. Primärtumör belägen i testis. B.Tumör i retroperitoneala lymfkörtlar och patologiskt fynd vid ultraljudsundersökning av testis som leder till orchiectomi och histopatologisk undersökning visar ett ärr (fibrotiskt område) i testikeln utbränd tumör Request PDF | On May 20, 2017, Torgrim Tandstad and others published The ABC-study: A randomized phase III study comparing one course of adjuvant bleomycin, etoposide, and cisplatin (BEP) and one.

Swenoteca, Trondheim, Norway. 64 likes · 1 talking about this. A non profit Norwegain and Swedish organization commited to providing patients with testicular cancer optimal diagnosis, treatment and.. BAKGRUND Testikelcancer är idag en av få solida tumörsjukdomar med mycket stor möjlighet till bot. Sedan slutet av sjuttiotalet har det skett en dramatisk förbättring av överlevnaden från 10 % till idag drygt 95 %. Detta har skett framför allt tack vare kombinationskemoterapi med cis-platinum, men också tack vare förbättringar inom kirurgi och diagnostik (datortomografi samt [ In the ongoing SWENOTECA ABC-study, men with CSI seminoma and at least one risk factor are randomized to either one course of carboplatin AUC7 or one BEP. The data confirm surveillance as a good option for all patients with CSI seminoma. SWENOTECA has the same follow-up schedule for surveillance and adjuvant carboplatin

SWENOTECA testicular cancer guideline

  1. Sedan 1981 finns för patienter med testikelcancer gemensamma behandlingsprogram och fortlöpande studier, de så kallade SWENOTECA-programmen (Swedish Norweigan Testicular Cancer Project). Alla patienter med testikelcancer skall anmälas till SWENOTECA; från 1 januari 2012 till respektive Regionalt Cancercentrum och den nationella monitoreringen sköts från Regionalt Cancercentrum Syd i Lund
  2. om Behandlingsblankett - Kemoterapi Personnummer Namn Blanketten skickas till Regionalt Onkologiskt Centrum Klinik, sjukhus Läkare Behandling (En blankett vid varje ny typ av cytostatikabehandling) Orsak till behandling adjuvant (CS I) primärbehandling av metastatisk sjukdom bristande effekt av föregående behandlin
  3. om Behandlingsblankett - Radioterapi Personnummer Namn Blanketten skickas till Regionalt Onkologiskt Centrum Klinik, sjukhus Läkare Behandling (En blankett för varje angivet target vid varje ny strålbehandlingsomgång) Orsak till strålbehandling adjuvant (CS I) primärbehandling av metastatisk sjukdo
  4. Swenoteca, Trondheim, Norway. 62 likes. A non profit Norwegain and Swedish organization commited to providing patients with testicular cancer optimal diagnosis, treatment and follow-up
  5. Hege Sagstuen Haugnes's 20 research works with 26 citations and 429 reads, including: Location and histology of retroperitoneal metastases in post-chemotherapy retroperitoneal lymph node.
  6. om Author: Mona Martinsson Created Date: 2/14/2017 12:32:32 PM.
  7. e whether specific microRNA in patient blood samples can improve the detection of patients with testicular cancer who.

SWENOTECA Seminom Behandlingsblankett - Kirurgi Personnummer Namn Blanketten skickas till Regionalt Onkologiskt Centrum Klinik, sjukhus Läkare Denna blankett ifylles för varje typ av kirurgiskt ingrepp (förutom primär orchiectomi = registreringsblankett) Kirurgi Datum år mån Sjukhus där kirurgi har utförtsdag , spe SweNat AB,556916-8122 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, varumärken, adress mm för SweNat A Gabriella Elisabeth Cohn-Cedermark's 7 research works with 19 citations and 140 reads, including: Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma Kontaktuppgifter till Swenec AB STOCKHOLM, adress, telefonnummer, se information om företaget

SWENOTECA Seminom Uppföljningsblankett Personnummer Namn Blanketter skickas till Regionalt Onkologiskt Centrum Klinik, sjukhus Läkare Besöksdatum år mån dag Status inga tecken på sjukdom stabil eller minskande resttumör recidiv/progress kontralateral testikelcancer annan. Carl Wilhelm Langberg's 6 research works with 14 citations and 104 reads, including: Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminom Swecato AB,556339-9632 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för Swecato A Hitta information om Swenec AB. Adress: Gröndalsvägen 148, Postnummer: 117 68

The ABC-study: A randomized phase III study comparing one course of adjuvant bleomycin, etoposide, and cisplatin (BEP) Based on SWENOTECA data from one course of adjuvant carboplatin AUC7 we estimate the relapse rate in patients with one or two risk factors to be 9 % Currently, a randomized phase III clinical trial (SWENOTECA-ABC Study) is comparing efficacy of one course of adjuvant BEP chemotherapy with one course of adjuvant carboplatin (NCT02341989) . The primary endpoint is disease recurrence in CS I seminoma patients with one or two risk factors (tumor size over 4 cm and/or stromal invasion of the rete testis by tumor cells) Sponsor Protocol Number: SWENOTECA-ABC-1: Start Date *: 2015-02-26: Sponsor Name: St Olavs University Hospital Full Title: A Randomized Phase III Study Comparing One Course of Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) and One Course of Carboplatin AUC7 in Clinical Stage I Seminomatous Testicular Cance BACKGROUND: The SWENOTECA IV protocol from 1995 is a prospective population-based study in metastatic non-seminomatous germ cell testicular cancer (NSGCT), designed for early identification of patients with poor response to standard cisplatin-based chemotherapy Request PDF | The SWENOTECA group: A good example of continuous binational and multidisciplinary collaboration for patients with testicular cancer in Sweden and Norway | The aim of this article is.

BACKGROUND SWENOTECA has since 1998 offered patients with clinical stage I (CS I) nonseminoma, adjuvant chemotherapy with one course of bleomycin, etoposide and cisplatin (BEP). The aim has been to reduce the risk of relapse, sparing patients the need of toxic salvage treatment. Initial results on 312 patients treated with one course of adjuvant BEP, with a median follow-up of 4.5 years, have. During a 5-year period (1981-86) 588 consecutive patients with nonseminatous germ cell tumors of the testis were included into a prospective Swedish-Norwegian multicenter study (SWENOTECA) and clinically staged according to the Royal Marsden system. A total of 370 patients (63%) had early clinical stages (CS) of disease; 295 (50%) had CS1, 32 (5%) had CS1Mk+ (CS1 with pathological serum tumor. Request PDF | Imatinib may reduce chemotherapy-induced pneumonitis. A report on four cases from the SWENOTECA | Background: An increasing number of anticancer drugs have been reported to cause.

Chicago, IL (UroToday.com) Dr. Tandstad and colleagues presented their study design of the ABC study, a randomized phase III study comparing one course of adjuvant bleomycin, etoposide, and cisplatin (BEP) and one course of carboplatin among patients with stage I seminoma testicular cancer, at today's ASCO 2017 annual meeting Men with clinically localized, stage I testicular cancer have an excellent prognosis, regardless of management. Non-risk-adapted active surveillance is an attractive management option for men with clinical stage I testicular cancer, which offers outstanding long-term cancer cure while sparing most patients treatment by avoiding prophylactic chemotherapy, radiation, or surgery

Surveillance b. BEP × 1 c. Surveillance b. BEP × 1 c. Surveillance b. BEP × 1 c.; Number of patients 1000 1000 1000 1000 1000 1000 Relapses 250 21 500 3 Table 4. Assumed burden of chemotherapy, different treatment strategies - One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group SWENOTECA has since 1998 offered patients with clinical stage I (CS I) nonseminoma, adjuvant chemotherapy with one course of bleomycin, etoposide and cisplatin (BEP). The aim has been to reduce the risk of relapse, sparing patients the need of toxic salvage treatment Testicular Cancer Group (SWENOTECA) HEGE S. HAUGNES 1,2, ANNA LAURELL 3, ULRIKA STIERNER 4, 1,2ROY M. BREMNES , OLAV DAHL 5,6, EVA CAVALLIN-ST Å HL 7 & GABRIELLA COHN-CEDERMARK PDF | Aim: Characteristics, treatment and outcome of patients (pts) with brain metastases (BMet) from GCT are largely unknown due to a lack of data. We... | Find, read and cite all the research.

Den kliniske forskningen ved testikkelkreft ved Oslo universitetssykehus foregår i hovedsak som del av Swedish and Norwegian Testicular Cancer Group (SWENOTECA). Page visits: 243 Home Urological oncology Testicular Cancer Research Grou Background. The SWENOTECA IV protocol from 1995 is a prospective population-based study in metastatic non-seminomatous germ cell testicular cancer (NSGCT), designed for early identification of patients with poor response to standard cisplatin-based

Extensively treated TCSs, but not those on surveillance or limited treatment, are at increased risk of work loss long-term, not explained by relapse. These patients may benefit from early rehabilitation initiatives Hoppa till huvudinnehåll. Meny. Anställning. Arbetsmiljö och hälsa. Din hälsa. Friskvård; Rehabiliterin Abstract Today, percutaneous transluminal coronary angioplasty (PTCA) is the most important treatment modality for coronary artery disease. However, restenosis occurs in 20-40% of the vessels in spite of the use of stents Journals & Books; Register Sign in. Sign in Registe Introduction: Germ cell tumors of testis are the most common solid tumors in men 20 to 35 years of age. It is considered a model of curable malignancy. With the access to the treatment, germ-cell tumors are curable even in the presence of metastatic disease. Unfortunately, many patients do not have the opportunity to receive any treatment because of personal economic problems compromising.

Management programs swenoteca

  1. omatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA). Haugnes HS, Laurell A, Stierner U, Bremnes RM, Dahl O, Cavallin-Ståhl E, Cohn-Cedermark G Acta Oncol 2012 Feb;51(2):168-76
  2. Semantic Scholar profile for P A Høisaether, with 2 highly influential citations and 1 scientific research papers
  3. Semantic Scholar profile for L. Baldetorp, with 6 highly influential citations and 20 scientific research papers
  4. Skip to main content. swedish website; Menu. Home; International Admissions. Why study at Lund Universit

About swenoteca

Refine search result. 1 - 33 of 33 Cite Export Link to result lis Change search. SWENOTECA testicular cancer guidelines. Protocol VIII and IX; Prosedyrer i Oncolex kan ikke erstatte faglig veiledning fra kvalifisert veileder. Den som følger prosedyrene har et selvstendig ansvar for at det foreligger nødvendig godkjenning, lisens eller autorisasjon PURPOSE: Evaluate effects of electro-acupuncture (EA) and hormone therapy (HT) on health-related quality-of-life (HRQoL) and sleep in breast cancer survivors with vasomotor sympt Open this publication in new window or tab >> Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA

SWENOTECA

copy and paste the html snippet below into your own page liu.se Search for publications in DiVA Simple search Advanced search - Research publications Advanced search - Student theses Statistics Advanced search - Research publications Advanced search - Student theses Statistic Purpose: To evaluate the effect of magnetic resonance (MR) imaging (MRI) geometric distortions on head and neck radiation therapy treatment planning (RTP) for an MRI-only RTP. W Clinical trials for Cancer AND Cisplatin The European Union Clinical Trials Register allows you to search for protocol and results information on

Swenoteca

Research pages of Testicular Cancer Research Group. Oslo University Hospital is responsible for the oncological treatment of patients with testicular cancer in the South-Eastern health region of Norway ZusammenfassungDer Hodentumor ist in Deutschland der häufigste bösartige Tumor bei jungen Männern im Alter von 20-40 Jahren. Aus bislang ungeklärter Ursache zeigt dieser Tumor in westlichen Ländern eine steigende Inzidenz. Die Zahl der Erkrankungsfälle ist in den letzten 30 Jahren um 50% gestiegen und beträgt heute ca. 11/100 000. Die bei optimaler Therapie erzielbare hohe.

Mailing list swenoteca

  1. What's known on the subject? and What does the study add? There are few large‐scale follow‐up studies regarding psychological reactions among men diagnosed with testicular cancer; therefore, our kn..
  2. A report on four cases from the SWENOTECA Acta Oncol, 57 (10), 1401-1406 DOI 10.1080/0284186X.2018.1479072, PubMed 29869895 Publications 2016 Tandstad T , Ståhl O , Dahl O , Haugnes HS , Håkansson U , Karlsdottir Å , Kjellman A , Langberg CW , Laurell A , Oldenburg J , Solberg A , Söderström K , Stierner U , Cavallin-Ståhl E , Wahlqvist R , Wall N , Cohn-Cedermark

Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus

2016-12-01 MLA ANMÄLNINGSBLANKETT Testikulärt Seminom 1. Definition av testikulär primärtumör (ICD C 62): A. Primärtumör belägen i testis. B.Tumör i retroperitoneala lymfkörtla During a 5-year period (1981-86) 588 consecutive patients with nonseminatous germ cell tumors of the testis were included into a prospective Swedish-

Follow-up swenoteca

Nonseminoma swenoteca

Enter words / phrases / DOI / ISBN / authors / keywords / etc. Search in N1-3 M0 (Clincal stage II A/B/C) Relapse-free survival for patients with stage II A / B seminoma is approximately 95% and 90% at 6 years, respectively. Tansdstad T et al. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program. J Clin Oncol. 2009 May 1;27(13):2122-8 Find all the evidence you need on Etoposide via the Trip Database. Helping you find trustworthy answers on Etoposide | Latest evidence made eas

Early clinical stages (CS1, CS1MK+ and CS2A) of non-seminomatous testis cancer: Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastase The Impact of Testicular Carcinoma and its Treatment on Sperm DNA Integrity Olof Ståhl, M.D. 1 Jakob Eberhard, M.D. 1 Katarina Jepson2 Marcello Spano, Ph.D. 3.

Purpose. Lymphovascular invasion (LVI) is an important step in bladder cancer cell dissemination. We aimed to perform a systematic review and meta-analysis of the literature to assess the prognostic value of LVI in radical cystectomy (RC) specimens Issuu is a digital publishing platform that makes it simple to publish magazines, catalogs, newspapers, books, and more online. Easily share your publications and get them in front of Issuu's.

Open this publication in new window or tab >> Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: A Nordic population-based case-control stud SwePub sökning: db:Swepub. Baker, J. H., et al. (författare) Sex differences and developmental stability in genetic and environmental influences on psychoactive substance consumption from early adolescence to young adulthoo The Virtual Health Library is a collection of scientific and technical information sources in health organized, and stored in electronic format in the countries of the Region of Latin America and the Caribbean, universally accessible on the Internet and compatible with international databases Testicular cancer is a highly treatable, usually curable, cancer that most often develops in young and middle-aged men. Most testicular cancers are germ cell tumors.For treatment planning, germ cell tumors are broadly divided into seminomas and nonseminomas because they have different prognostic and treatment algorithms. For patients with seminoma (all stages combined), the cure rate exceeds 90%

The ABC-study: A randomized phase III study comparing one

  1. liu.se Search for publications in DiVA Simple search Advanced search - Research publications Advanced search - Student theses Statistic
  2. As oncological treatment might impair the patients' fertility, male cancer patients are offered to cryopreserve semen prior to treatment. Impaired sperm DNA quality is associated with reduced fertility,..
  3. Skip header and navigation. Home. View Selections: 0 Items Hel
  4. Refine search resul

Swenoteca - About Faceboo

Testicular ca [edmond] 1. Testicular Ca Dr. Edmond Wong EAU 2010 EAU 2011EGCCCG 2008 (EU) 1 2. Epidemiology• 1-1.5% of male neoplasm• 5% of urological tumors• 3-6 new case per 100,000 male/ year• Increasing trend towards increase incidence• 1-2% bilateral• Histological variance: - Germ cell tumors (90%) - Non- GCT (10%)• Peak incidence: - 30s for seminoma - 40s for pure. 1: Review: Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors. 2015 Haugnes, Hege S / Oldenburg, Jan / Bremnes, Roy M.· Department of Oncology, University Hospital of North Norway, Tromsø, Norway; Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway. Electronic address: hege.sagstuen.haugnes@uit.no. · Department of Oncology, Oslo.

Testikelcancer - Internetmedici

liu.se Search for publications in DiVA Enkelt søk Avansert søk - Forskningspublikasjoner Avansert søk - Studentoppgaver Statistik ONCOLOGY Sexual Dysfunction and Reproductive Concerns in Young Men Diagnosed With Testicular Cancer: An Observational Study L. Ljungman, PhD,1 L. E. Eriksson, PhD,2,3. Digitala Vetenskapliga Arkivet Enkel sökning Avancerad sökning - Forskningspublikationer Avancerad sökning - Studentuppsatser Statisti ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016 Christian Dittrich,1 Michael Kosty,2 Svetlana Jezdic,3 Doug Pyle,4 Rossana Berardi,5 Jonas Bergh,6 Nagi El-Saghir,7 Jean-Pierre Lotz,8 Pia Österlund,9 Nicholas Pavlidis,10 Gunta Purkalne,11 Ahmad Awada,12 Susana Banerjee,13 Smita Bhatia,14 Jan Bogaerts,15 Jan Buckner,16 Fatima Cardoso,17 Paolo Casali,18.

Treatment of stage I seminoma, with one course of adjuvant

doi: 10.1111/joim.12303 Review of 103 Swedish Healthcare Quality Registries L. Emilsson1,2,3, B. Lindahl4,M.K€oster 5, M. Lambe6,7 & J. F. Ludvigsson6,8 From the 1Primary Care Research Unit, Vardcentralen V€armlands Nys ater, V€ armland County;€ 2School of Health and Medical Sciences, Orebro University,€ Orebro, Sweden;€ 3Department of Health Management and Health Economy.

  • Rostfri plåt.
  • Kristen stewart age.
  • Ü30 party stuttgart 2018.
  • Veranstaltungen bezirk korneuburg.
  • Rädd för att komma för tidigt.
  • Oxymoron examples.
  • Hyra cykel i borås.
  • Bitmoji snapchat.
  • Bokföra varulager bokslut.
  • Hct blodprov.
  • Lidl äppeljuice.
  • Corsair rm750x prisjakt.
  • Var tillverkas kia rio.
  • Tempat ngerjain tugas di surabaya.
  • Mackmyra första utgåvan pris.
  • Ung mamma blogg 14 år.
  • Slipknot mask sverige.
  • Sjömansbiff i ugn med öl.
  • Pflegeeltern für flüchtlingskinder nrw.
  • Datura poison.
  • Virkade dukar tapetklister.
  • Beauty & the beast rollista.
  • Kärcher k3 prisjakt.
  • Duroc gris fakta.
  • Tortyr.
  • Tanzschule velbert langenberg.
  • Hungarian language.
  • Hotellfrukost kiruna.
  • Ariadne von schirach ich und du und müllers kuh.
  • Alda i mash.
  • Brian whittaker model.
  • Kpop album sverige.
  • Kalorienzähler app kostenlos.
  • Madame tussauds star wars.
  • Spelbutiken.
  • Uhrzeit spanien.
  • Högskolan borås ping pong.
  • Körkarl mas.
  • Temperaturövervakning på distans.
  • Sur keso.
  • Charlotte haid bondergaard hästar.